FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808372284> ?p ?o ?g. }

• W2808372284 endingPage "233" @default.
• W2808372284 startingPage "223" @default.
• W2808372284 abstract "This randomized, phase 1, single-dose, crossover study (NCT02189304) compared the 12-hour pharmacokinetic (PK) and safety profiles of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (BGF MDI) 320/14.4/10 μg and budesonide/formoterol fumarate dihydrate (BFF) MDI 320/10 μg (both formulated using innovative co-suspension delivery technology) to an active comparator (budesonide/formoterol fumarate dihydrate dry powder inhaler [BUD/FORM DPI] 320/9-μg delivered dose) in healthy adults. The potential for PK interaction between glycopyrronium and budesonide/formoterol within BGF MDI was assessed. Of 72 subjects randomized, 59 completed treatment. Systemic budesonide exposure (primary objective) based on area under the plasma drug concentration-time curve 0-12 hours (AUC0-12 ; % coefficient of variation) was 1598.38 (49.7), 1657.09 (50.4), and 1276.75 (70.4) pg·h/mL for BGF MDI, BFF MDI, and BUD/FORM DPI, respectively; and formoterol exposure (AUC0-12 [% coefficient of variation]) was 39.16 (45.9), 39.53 (40.5), and 23.24 (59.2) pg·h/mL, respectively. BGF MDI and BFF MDI were bioequivalent for budesonide and formoterol. All treatments were well tolerated. While systemic exposure to budesonide and formoterol was higher for BGF MDI and BFF MDI than for BUD/FORM DPI, there were no appreciable differences in the incidence of pharmacologically predictable adverse events. This, coupled with the absence of PK interactions, suggests the BGF MDI safety profile will be comparable to BUD/FORM DPI." @default.
• W2808372284 created "2018-06-21" @default.
• W2808372284 creator A5002361764 @default.
• W2808372284 creator A5002603430 @default.
• W2808372284 creator A5004903602 @default.
• W2808372284 creator A5011502862 @default.
• W2808372284 creator A5077419098 @default.
• W2808372284 date "2018-06-14" @default.
• W2808372284 modified "2023-10-16" @default.
• W2808372284 title "Pharmacokinetics of Co‐Suspension Delivery Technology Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate (BGF MDI) and Budesonide/Formoterol Fumarate Dihydrate (BFF MDI) Fixed‐Dose Combinations Compared With an Active Control: A Phase 1, Randomized, Single‐Dose, Crossover Study in Healthy Adults" @default.
• W2808372284 cites W1513180089 @default.
• W2808372284 cites W1585978007 @default.
• W2808372284 cites W1784924894 @default.
• W2808372284 cites W1890874870 @default.
• W2808372284 cites W1930304162 @default.
• W2808372284 cites W1972693426 @default.
• W2808372284 cites W1976421392 @default.
• W2808372284 cites W1980016322 @default.
• W2808372284 cites W1987343787 @default.
• W2808372284 cites W2023554430 @default.
• W2808372284 cites W2029194066 @default.
• W2808372284 cites W2069984535 @default.
• W2808372284 cites W2086199047 @default.
• W2808372284 cites W2090422762 @default.
• W2808372284 cites W2095666112 @default.
• W2808372284 cites W2101909755 @default.
• W2808372284 cites W2105281080 @default.
• W2808372284 cites W2119061500 @default.
• W2808372284 cites W2125065061 @default.
• W2808372284 cites W2145152803 @default.
• W2808372284 cites W2159477321 @default.
• W2808372284 cites W2159837316 @default.
• W2808372284 cites W2177915374 @default.
• W2808372284 cites W2317895461 @default.
• W2808372284 cites W2331048833 @default.
• W2808372284 cites W2331642892 @default.
• W2808372284 cites W2336500161 @default.
• W2808372284 cites W2513086234 @default.
• W2808372284 cites W2561355144 @default.
• W2808372284 cites W2568255753 @default.
• W2808372284 cites W2604577460 @default.
• W2808372284 cites W2604743750 @default.
• W2808372284 cites W2761239349 @default.
• W2808372284 cites W2781655071 @default.
• W2808372284 cites W2791166705 @default.
• W2808372284 doi "https://doi.org/10.1002/cpdd.585" @default.
• W2808372284 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6585691" @default.
• W2808372284 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29901860" @default.
• W2808372284 hasPublicationYear "2018" @default.
• W2808372284 type Work @default.
• W2808372284 sameAs 2808372284 @default.
• W2808372284 citedByCount "12" @default.
• W2808372284 countsByYear W28083722842018 @default.
• W2808372284 countsByYear W28083722842019 @default.
• W2808372284 countsByYear W28083722842020 @default.
• W2808372284 countsByYear W28083722842021 @default.
• W2808372284 countsByYear W28083722842022 @default.
• W2808372284 countsByYear W28083722842023 @default.
• W2808372284 crossrefType "journal-article" @default.
• W2808372284 hasAuthorship W2808372284A5002361764 @default.
• W2808372284 hasAuthorship W2808372284A5002603430 @default.
• W2808372284 hasAuthorship W2808372284A5004903602 @default.
• W2808372284 hasAuthorship W2808372284A5011502862 @default.
• W2808372284 hasAuthorship W2808372284A5077419098 @default.
• W2808372284 hasBestOaLocation W28083722841 @default.
• W2808372284 hasConcept C112705442 @default.
• W2808372284 hasConcept C126322002 @default.
• W2808372284 hasConcept C197934379 @default.
• W2808372284 hasConcept C2776042228 @default.
• W2808372284 hasConcept C2776136866 @default.
• W2808372284 hasConcept C2776954882 @default.
• W2808372284 hasConcept C2777419714 @default.
• W2808372284 hasConcept C2777450039 @default.
• W2808372284 hasConcept C2779871671 @default.
• W2808372284 hasConcept C2780261241 @default.
• W2808372284 hasConcept C2780667556 @default.
• W2808372284 hasConcept C2909086917 @default.
• W2808372284 hasConcept C42219234 @default.
• W2808372284 hasConcept C71924100 @default.
• W2808372284 hasConcept C98274493 @default.
• W2808372284 hasConceptScore W2808372284C112705442 @default.
• W2808372284 hasConceptScore W2808372284C126322002 @default.
• W2808372284 hasConceptScore W2808372284C197934379 @default.
• W2808372284 hasConceptScore W2808372284C2776042228 @default.
• W2808372284 hasConceptScore W2808372284C2776136866 @default.
• W2808372284 hasConceptScore W2808372284C2776954882 @default.
• W2808372284 hasConceptScore W2808372284C2777419714 @default.
• W2808372284 hasConceptScore W2808372284C2777450039 @default.
• W2808372284 hasConceptScore W2808372284C2779871671 @default.
• W2808372284 hasConceptScore W2808372284C2780261241 @default.
• W2808372284 hasConceptScore W2808372284C2780667556 @default.
• W2808372284 hasConceptScore W2808372284C2909086917 @default.
• W2808372284 hasConceptScore W2808372284C42219234 @default.
• W2808372284 hasConceptScore W2808372284C71924100 @default.
• W2808372284 hasConceptScore W2808372284C98274493 @default.
• W2808372284 hasIssue "2" @default.
• W2808372284 hasLocation W28083722841 @default.
• W2808372284 hasLocation W28083722842 @default.

• next